The global bovine mastitis market revenue was around US$ 0.94 billion in 2021 and is estimated to reach US$ 1.09 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period from 2022 to 2031.
Bovine mastitis is an inflammatory response of the mammary gland's udder tissue due to microbial infections or physical damage. It is regarded as the most common illness that causes financial loss in the dairy sector because of decreased yield and poor milk quality.
Factors Influencing Market Growth
The rising incidence of cow injuries and the prevalence of bovine mastitis propels the market growth.
Increase in dairy farms and the production of dairy products. Thus it is anticipated to drive the market growth.
Rising government and non-government initiatives as well as increased funding for veterinary treatment. Such factors boost the market.
Several major market players are concentrating on R&D operations to produce drugs for bovine mastitis as the growing number of dairy animals, which also contributes to the market expansion
Many key market players are focusing on R&D activities to develop drugs for bovine mastitis as the dairy animal population is increasing, which also contributes to market growth.
Study of the COVID-19 Pandemic
The COVID-19 pandemic had a negative impact on bovine mastitis on the market. Due to the lockdown enacted by the government, the supply chain for farms and the dairy industry was halted. During the pandemic, the whole healthcare sector has concentrated on items that save lives and are related to COVID-19, which limits the treatment of cow mastitis. The healthcare industry has undergone restructuring to provide safer healthcare facilities. Thus, it is projected that the market will expand in post-pandemic circumstances.
Asia-Pacific accounted for the largest share of the market. Due to its established animal healthcare infrastructure, breakthroughs in treating bovine mastitis, and the region's abundance of dairy farms. These factors fuel the market growth in this region.
However, LAMEA is anticipated to develop significant growth because of an increase in product releases there, an increase in spending healthcare on care for animals, and a rise in the number of dairy farms. Such factors drive the market in this region.
The leading competitors in the global bovine mastitis market are:
Boehringer Ingelheim Gmbh
Forte Healthcare Ltd
Thermo Fisher Scientific Inc
The global bovine mastitis market segmentation focuses on Product, Route of Administration, Application and Region.
Segmentation based on Product
Segmentation based on Route of Administration
Segmentation based on Application
Veterinary Hospitals and Clinics
? Mild Cases
? Moderate Cased
? Severe Cases
? Mild Cases
? Moderate Cases
? Severe Cases
Segmentation based on Region
Rest of Western Europe
Rest of Europe
Australia & New Zealand
Rest of Asia Pacific
Middle East & Africa (MEA)
Rest of MEA
Rest of South America